Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms

dc.creatorSangenito, Leandro S.
dc.creatorMenna-Barreto, Rubem F. S.
dc.creatorOliveira, Ana Carolina
dc.creatord`Avila-Levy, Claudia M.
dc.creatorBranquinha, Marta H.
dc.creatorSantos, André L. S.
dc.date.accessioned2018-10-11T12:09:56Z
dc.date.accessioned2023-09-05T15:24:26Z
dc.date.available2018-10-11T12:09:56Z
dc.date.available2023-09-05T15:24:26Z
dc.date.created2018-10-11T12:09:56Z
dc.date.issued2018
dc.identifierSANGENITO, Leandro S. et al. Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms. International Journal of Antimicrobial Agents, v.52, p.185–194, 2018.
dc.identifier0924-8579
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/29506
dc.identifier10.1016/j.ijantimicag.2018.03.021
dc.identifier1872-7913
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8665619
dc.languageeng
dc.publisherElsevier
dc.rightsrestricted access
dc.titlePrimary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms
dc.typeArticle


Este ítem pertenece a la siguiente institución